A scintigraphic study to evaluate the deposition patterns of a novel anti-asthma drug inhaled from the cyclohaler dry powder inhaler

Advanced Drug Delivery Reviews

Volumn 26, Issue 1, 1997, Pages 59-67

  Pitcairn, G R ^a   Hooper, G ^a   Luria, X ^b   Rivero, X ^b   Newman, S P ^a  

^a PHARMACEUTICAL PROFILES LTD   (United Kingdom)

^b Research Centre ^*  (Spain)

Author keywords

Gamma scintigraphy; Pharmacokinetics; Total and regional lung deposition

Indexed keywords

BIOMEDICAL EQUIPMENT; DEPOSITION; DRUG DOSAGE; DRUG PRODUCTS; GAMMA RAYS; PHARMACOKINETICS;

ANTIASTHMA DRUGS; DRY POWDER INHALERS; SCINTIGRAPHY;

CONTROLLED DRUG DELIVERY;

ANTIASTHMATIC AGENT; AROFYLLINE; UNCLASSIFIED DRUG;

ARTICLE; ASTHMA; CLINICAL TRIAL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DISPOSITION; DRUG FORMULATION; DRUG HALF LIFE; DRY POWDER; FEMALE; HUMAN; HUMAN EXPERIMENT; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; MALE; NORMAL HUMAN; POWDER INHALER; PRIORITY JOURNAL; SCINTIGRAPHY;

EID: 0031560947     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(97)00511-5     Document Type: Review

References (22)

1. Clark, T.J.H., Godfrey S. and Lee, T.H. (1992) Asthma, 3rd ed. Chapman Hall, London.
2. Newman, S.P. (1991) Aerosol generators and delivery systems. Respiratory Care 36(9), 939-951.
3. Timsina, M.P., Martin, G.P., Marriott, C., Ganderton, D. and Yianneskis, M. (1994) Drug delivery to the respiratory tract using dry powder inhalers. Int. J. Pharm. 101, 1-13.
4. Newman, S.P. (1993) Scintigraphic assessment of therapeutic aerosols. In: Critical Reviews in Therapeutic Drug Carrier Systems. CRC Press, pp. 65-109.
5. Pitcairn, G.R., Lunghetti, G., Ventura, P. and Newman, S.P. (1994) A comparison of the lung deposition of salbutamol inhaled from a new dry powder inhaler, at two inhaled flow rates. Int. J. Pharm. 102, 11-18.
6. Quanjer, P.H. (1983) Standardised lung function testing. Bull. Eur. Physiopathol. Respir. 19 (Suppl. 5), 7-95.
7. Newman, S.P., Clark, A.R., Talaee, N. and Clarke, S.W. (1989) Pressurised aerosol deposition in the human lung with and without an 'open' spacer device. Thorax 44, 706-710.
8. Fleming, J.S. (1979) A technique for the absolute measurement of activity using a gamma camera and computer. Phys. Med. Biol. 24(1), 176-180.
9. Ganderton, D. and Kassem, N.M. (1992) Dry powder inhalers. In: D. Ganderton and T. Jones (Eds.), Advances in Pharmaceutical Sciences. Academic Press, London, pp. 165-191.
10. Byron, P.R. (1992) Towards the rational formulation of metered dose inhalers. J. Biopharin. Sci. 3, 1-9.
11. Newman, S.P., Clark, A.R., Talaee, N. and Clarke, S.W. (1991) Lung deposition of 5 mg Intal from a pressurised metered dose inhaler assessed by radiotracer technique. Int. J. Pharm. 74, 203-208.
12. Newman, S.P. (1993) Therapeutic aerosol deposition in man. In: F. Morén, M.B. Dolovich, M.T. Newhouse and S.P. Newman (Eds.), Aerosols in Medicine: Principles, Diagnosis and Therapy. Elsevier, Amsterdam, pp. 375-396.
13. Zanen, P., Van Spiegel, P.I, Van der Kolk, H., Tushuizen, E. and Enthoven, R. (1992) The effect of the inhalation flow on the performance of a dry powder inhalation system. Int. J. Pharm. 81, 199-203.
14. Vidgren, M., Karkkainen, A., Karjalainen, P., Paronen, P. and Nuutinen, J. (1988) Effect of powder inhaler design on drug deposition in the respiratory tract. Int. J. Pharm. 42, 211-216.
15. Biddiscombe, M.F., Melchor, R., Mak, V.H.F., Marriott, R.J., Taylor, A.J., Short, M.D. and Spiro, S.G. (1993) The lung deposition of salbutamol, directly labelled with Tc-99m, delivered by pressurised metered dose inhalers and dry powder inhalers. Int. J. Pharm. 91, 111-121.
16. Newman, S.P., Morén, F., Trofast, E., Talaee, N. and Clarke, S.W. (1991) Terbutaline sulphate Turbuhaler: Effect of inhaled flow rate on drug deposition and efficacy. Int. J. Pharm. 74, 209-213.
17. Borgström, L. and Newman, S.P. (1993) Total and regional lung deposition of terbutaline sulphate inhaled via a pressurised MDI or via Turbuhaler. Int. J. Pharm. 97, 47-53.
18. Borgström, L., Bondesson, E., Morén, F., Trofast, E. and Newman, S.P. (1994) Lung deposition of budesonide inhaled via Turbuhaler: A comparison with terbutaline sulphate in normal subjects. E. Respir. J. 7, 69-73.
19. Auty, R.M., Brown, K., Neale, M.G. and Snashall, P.D. (1987) Respiratory tract deposition of sodium cromoglycate is highly dependant upon technique of inhalation using the spinhaler. Br. J. Dis. Chest. 81, 371-380.
20. Richards, R., Simpson, S.F., Renwick, A.G. and Holgate, S.T. (1988) Inhalation rate of sodium cromoglycate determines plasma pharmacokinetics and protection against AMP-induced bronchoconstriction in asthma. Eur. Respir. J. 1, 896-901.
21. Borgström, L. and Nilsson, M. (1990) A method for determination of the absolute pulmonary bioavailability of inhaled drugs: Terbutaline. Pharm. Res. 7(10), 1068-1070.
22. Taylor, G., Colthorpe, P. and Farr, S.J. (1994) Pulmonary absorption of proteins: Influence of deposition site and competitive elimination processes. In: P.R. Byron, R.N. Dalby, S.J. Farr (Eds.), Respiratory Drug Delivery IV. Virgina, USA, pp. 25-30.